NCLAT: Can File App. u/s 7 of IBC when Entire Liability Not Discharged after Selling Pledged Shares || NCLAT: Recovery Proceedings before DRT doesn’t Prohibit Financial Creditors from Filing App. u/s 7 || Ker. HC: Women Face Discrimination at Multiple Level Due to their Inter- Sectionality || Del. HC: Amounts Received by ERC under Filing Fee, Tariff Fee Not Exigible to Tax || Ker. HC: Equity, Justice, Convenience Govern the Question Whether Joint Trial is Required or Not || Ker. HC: Equity, Justice, Convenience Govern the Question Whether Joint Trial is Required or Not || Delhi HC: Benchmark of Rs. 50 Lakh Income to be Met at Initiation of Reassessment Proceedings || MP HC: No Prohibition on Issuance of Passport without Father’s Consent || Del. HC: Samsung India Electronics is Not Samsung Korea’s Permanent Establishment in India || Guj. HC: Machines Used for Welding in Residential Society is Nuisance

Search Results for Tag : Glenmark Pharmaceuticals

News

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets(22.12.2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty P.....

Tags : Glenmark Pharmaceuticals Inc, Forest Laboratories, LLC, Forest Laboratories Holdings, , Royalty Pharma Collection Trust

Delhi HC Restrains Glenmark Pharmaceuticals from Manufacturing, Selling Zita and Zita-Met(07.10.2015)

Delhi High Court has restrained Glenmark Pharmaceuticals, an Indian firm, from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, sa.....

Tags : Delhi High Court,Glenmark Pharmaceuticals, Merck Sharp and Dohme, patent